50 related articles for article (PubMed ID: 8410303)
1. Gamma probe assisted ex vivo detection of small lymph node metastases following the administration of indium-111-labeled monoclonal antibodies to colorectal cancers.
Abdel Nabi H; Doerr RJ; Balu D; Rogan L; Farrell EL; Evans NH
J Nucl Med; 1993 Oct; 34(10):1818-22. PubMed ID: 8410303
[TBL] [Abstract][Full Text] [Related]
2. Pathology underrates colon cancer extranodal and nodal metastases; ex vivo radioimmunodetection helps staging.
Sézeur A; Châtelet FP; Cywiner Ch; de Labriolle-Vaylet C; Chastang C; Billotey C; Malafosse M; Gallot D; Betton P; Montravers F; Carvajal-Gonzalez S; Askienazy S; Talbot JN; Rain JD; Milhaud G; Saumon G; Barbet J; Gruaz-Guyon A
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5592s-5597s. PubMed ID: 17875794
[TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3.
Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A
J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429
[TBL] [Abstract][Full Text] [Related]
4. [Immunoscintigraphy with MAb B72.3 for preoperative detection of lymph node metastases of colorectal carcinoma].
Mörschel M; Bockisch A; Junginger T
Chirurg; 1995 May; 66(5):503-6. PubMed ID: 7607013
[TBL] [Abstract][Full Text] [Related]
5. Capromab pendetide imaging of occult lymph node metastases.
Haseman MK
J Nucl Med; 1998 Apr; 39(4):653. PubMed ID: 9544674
[No Abstract] [Full Text] [Related]
6. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
[TBL] [Abstract][Full Text] [Related]
7. Validation and feasibility of ex vivo sentinel lymph node "mapping" by methylene blue in colorectal cancer.
Ceranic MS; Kecmanovic DM; Pavlov MJ; Nale DP; Micev MT; Kovacevic PA; Stamenkovic AB
Hepatogastroenterology; 2010; 57(102-103):1113-8. PubMed ID: 21410041
[TBL] [Abstract][Full Text] [Related]
8. [Mapping the sentinel lymph node ex vivo and finding the micrometastasis by CK-immunostaining in carcinoma of the colon and rectum].
Wang FL; Pan ZZ; Wan DS
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):994-7. PubMed ID: 16194357
[TBL] [Abstract][Full Text] [Related]
9. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
[TBL] [Abstract][Full Text] [Related]
10. A new concept for the role of ex vivo sentinel lymph nodes in node-negative colorectal cancer.
Märkl B; Arnholdt HM; Jähnig H; Spatz H; Anthuber M; Oruzio DV; Kerwel TG
Ann Surg Oncol; 2010 Oct; 17(10):2647-55. PubMed ID: 20333553
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunodetection of colorectal carcinoma with 111In-labelled monoclonal antibody IVP ZCE 025 (a tissue culture-produced anti-CEA MAb).
Abdel-Nabi H; Doerr RJ; Evans NH; Farrell EE; Chan HW; Balu D; Gona J; Schweighardt S
Nucl Med Commun; 1994 Feb; 15(2):81-93. PubMed ID: 8170642
[TBL] [Abstract][Full Text] [Related]
12. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.
Abdel-Nabi HH; Schwartz AN; Goldfogel G; Ortman-Nabi JA; Matsuoka DM; Unger MW; Wechter DG
Radiology; 1988 Mar; 166(3):747-52. PubMed ID: 3277244
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
14. SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma.
Wagner A; Schicho K; Glaser C; Zettinig G; Yerit K; Lang S; Klug C; Leitha T
J Craniomaxillofac Surg; 2004 Dec; 32(6):343-9. PubMed ID: 15555515
[TBL] [Abstract][Full Text] [Related]
15. Cellular immunotherapy for patients with metastatic colorectal carcinoma using lymph node lymphocytes localized in vivo by radiolabeled monoclonal antibody.
Kim JA; Bresler HS; Martin EW; Aldrich W; Heffelfinger M; Triozzi PL
Cancer; 1999 Jul; 86(1):22-30. PubMed ID: 10391559
[TBL] [Abstract][Full Text] [Related]
16. Use of radiolabelled monoclonal antibodies in patients with primary and metastatic large bowel cancer.
Sergile SL; Haller DG; Daly JM
Surg Oncol; 1992 Dec; 1(6):391-8. PubMed ID: 1341276
[TBL] [Abstract][Full Text] [Related]
17. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.
Abdel-Nabi HH; Schwartz AN; Higano CS; Wechter DG; Unger MW
Radiology; 1987 Sep; 164(3):617-21. PubMed ID: 3303117
[TBL] [Abstract][Full Text] [Related]
18. Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
Kelty NL; Holder LE; Khan SH
J Nucl Med Technol; 1998 Sep; 26(3):174-7. PubMed ID: 9755436
[TBL] [Abstract][Full Text] [Related]
19. Validation of ex vivo lymphatic mapping in hematoxylin-eosin node-negative carcinoma of the colon and rectum.
Wong JH; Johnson DS; Namiki T; Tauchi-Nishi P
Ann Surg Oncol; 2004 Aug; 11(8):772-7. PubMed ID: 15249341
[TBL] [Abstract][Full Text] [Related]
20. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]